Qin et al.'s research further supports the tumor-suppressive role of ALDOB, showing that a ketogenic diet inhibits ALDOB enzymatic activity through lysine β-hydroxybutyrylation, leading to metabolic alterations that suppress glucose metabolism and mTOR signaling, ultimately inhibiting HCC cell proliferation 199. The gene discussed is MTOR; the disease is neoplasm.